Your browser is out of date
With an updated browser, you will have a better Medtronic web site experience. Update my browser now.
Addressing the opioid crisis
With minimally invasive treatment options for patients with VCFs
A 7-month retrospective claims analysis in Osteoporosis International shows balloon kyphoplasty (BKP) or vertebroplasty (VP) for vertebral compression fractures (VCF) reduced patient opioid use — and payer costs.1
A 7-month retrospective analysis compared opioid use and hospital visits in 8,845 patients before and after a BKP/VP procedure. Findings showed:
BKP is a minimally invasive therapy backed by powerful clinical evidence
KyphonTM balloon kyphoplasty relieves pain from the vertebral compression fractures by using orthopaedic balloons to restore vertebral height and correct angular deformity.2 After reduction, the balloons are deflated and removed. The resulting cavity allows for a controlled deposition of Kyphon bone cement, which helps form an internal cast and stabilize the fracture.
Risk statement
BALLOON KYPHOPLASTY INDICATION AND RISK STATEMENT
Kyphon™ Balloon Kyphoplasty is a minimally invasive procedure for the treatment of pathological fractures of the vertebral body due to osteoporosis, cancer, or benign lesion. Cancer includes multiple myeloma and metastatic lesions, including those arising from breast or lung cancer, or lymphoma. Benign lesions include hemangioma and giant cell tumor. The overall complication rate with the procedure has been demonstrated to be low.
Risks of acrylic bone cements include cement leakage, which may cause tissue damage, nerve or circulatory problems, and other serious adverse events, such as: cardiac arrest, cerebrovascular accident, myocardial infarction, pulmonary embolism, cardiac embolism. For complete information regarding indications for use, contraindications, warnings, precautions, adverse events, and methods of use, please reference the devices’ Instructions for Use included with the product.